zealand pharma | Home - Zealand Pharma A/S

Keyword	CPC	PCC	Volume	Score	Length of keyword
zealand pharma	0.61	0.7	9413	92	14
zealand	0.7	0.4	5079	65	7
pharma	0.05	0.8	2565	63	6

Keyword	CPC	PCC	Volume	Score
zealand pharma	1.98	0.4	4927	25
zealand pharma stock	1.57	0.5	9239	33
zealand pharma atkie	1.55	0.5	1382	40
zealand pharma share price	1.95	0.2	7686	23
zealand pharmaceuticals	1.82	1	5659	27
zealand pharma news	1.83	0.4	5220	52
zealand pharma nordnet	0.71	0.9	674	48
zealand pharma cours	1.19	0.1	9853	56
zealand pharma pipeline	0.07	0.5	1355	13
zealand pharma aktiekurs	1.76	0.1	2668	18
zealand pharma investor relations	0.2	0.7	6331	66
zealand pharma stock price	1.24	0.7	2235	96
pharmacy direct new zealand	1.25	0.6	7570	17
pharmacy council new zealand	0.61	0.7	9807	56
zealand pharma a/s	0.88	0.6	7804	76
zealand pharma aktie	0.96	1	4963	14
zealand pharma stock symbol	0.65	0.9	7455	19
zealand pharma ticker	0.07	0.6	2308	39

Search Results related to zealand pharma on Search Engine

Home - Zealand Pharma A/S
zealandpharma.com

https://www.zealandpharma.com/

WEBZealand Pharma A/S Sydmarken 11 2860 Søborg Denmark Tel +45 88 77 36 00 [email protected]

DA: 39 PA: 87 MOZ Rank: 23

Zealand Pharma | LinkedIn
linkedin.com

https://www.linkedin.com/company/zealand-pharma

WEBZealand Pharma | 27,491 followers on LinkedIn. Changing lives with next generation peptide therapeutics | Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company ...

DA: 53 PA: 22 MOZ Rank: 68

About Us - Zealand Pharma A/S
zealandpharma.com

https://www.zealandpharma.com/about/about-us/

WEBZealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development.

DA: 55 PA: 19 MOZ Rank: 70

Investor Relations - Zealand Pharma A/S
zealandpharma.com

https://www.zealandpharma.com/investor/investor-relations/

WEBInvestor relations. Zealand maintains an active approach to IR in order to provide transparency into our business and our activities. An open and transparent communication is the best way to maintain the confidence of our shareholders, and we achieve this through company announcements, investor meetings, company presentations, our company ...

DA: 8 PA: 80 MOZ Rank: 53

Zealand Pharma Announces Financial Results for the Full Year …
yahoo.com

https://finance.yahoo.com/news/zealand-pharma-announces-financial-results-060000936.html

WEBFeb 27, 2024 · Zealand Pharma Announces Financial Results for the Full Year 2023. Significant progress delivered across our obesity and rare disease assets while building a solid financial position. Positive...

DA: 100 PA: 44 MOZ Rank: 83

Zealand Pharma - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Zealand_Pharma

WEBZealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US.

DA: 28 PA: 38 MOZ Rank: 66

Zealand Pharma Announces FDA Approval of Zegalogue®
globenewswire.com

https://www.globenewswire.com/news-release/2021/03/22/2197267/0/en/Zealand-Pharma-Announces-FDA-Approval-of-Zegalogue-dasiglucagon-injection-for-the-Treatment-of-Severe-Hypoglycemia-in-People-with-Diabetes.html

WEBMar 22, 2021 · Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon) injection, for the Treatment of Severe Hypoglycemia in People with Diabetes. March 22, 2021 17:50 ET | Source: Zealand Pharma ...

DA: 11 PA: 74 MOZ Rank: 31

Zealand Pharma A/S (ZEAL.CO) - Yahoo Finance
yahoo.com

https://finance.yahoo.com/quote/ZEAL.CO

WEBFind the latest Zealand Pharma A/S (ZEAL.CO) stock quote, history, news and other vital information to help you with your stock trading and investing.

DA: 79 PA: 31 MOZ Rank: 59

Zealand Pharma soars 35% after promising weight-loss drug results
cnbc.com

https://www.cnbc.com/2024/02/26/novo-nordisk-and-eli-lilly-rival-soars-26percent-after-promising-test-results.html

WEBFeb 26, 2024 · Shares of Denmark’s Zealand Pharma rose 35% on Monday after results showed success in its liver disease treatment survodutide, which is also on trial as a drug to treat obesity. The trial ...

DA: 72 PA: 46 MOZ Rank: 2

Zealand Pharma Announces Global License and Development
globenewswire.com

https://www.globenewswire.com/news-release/2022/09/07/2511078/0/en/Zealand-Pharma-Announces-Global-License-and-Development-Agreement-with-Novo-Nordisk-for-ZEGALOGUE-dasiglucagon.html

WEBSep 7, 2022 · Company announcement – No. 38 / 2022. Agreement includes an upfront payment, development, regulatory, manufacturing and sales-based milestones of up to DKK 290 million to Zealand in addition to ...

DA: 71 PA: 44 MOZ Rank: 14